Medtech
CMR Surgical Limited announces that it has raised £195 million ($240 million) to fully fund the global commercialisation of the business.
Medical device maker Medtronic and Novo Nordisk have entered a collaboration pact to develop ways of integrating insulin dosing management data from future Novo Nordisk smart insulin pens into Continuous Glucose Monitoring devices from Medtronic.
In a move to develop medical devices faster, at a lower cost, and with a greater likelihood of a successful exit, Koa Accel announced its launch as a next generation medical device accelerator.
Sequana Medical NV announces that it will be attending the following upcoming scientific conferences
Polarean Imaging plc, the medical-imaging technology company, with a proprietary drug-device combination product for the magnetic resonance imaging market, announces that further to the announcement of 5 June 2019, the Company has delivered and installed its latest 9820 Xenon Polariser system at the Hospital for Sick Children in Toronto www.sickkids.ca.
To accelerate development and commercialisation of innovative Glaucoma MIGS device, MINIjectTM
Successful validation of standardized clinical procedure for instillation of nanoparticles in first patient cohort
AuroLase Therapy is a focal ablation treatment utilizing gold nanoparticles. The nanoparticles heat and destroy cancer cells.
Advanced composite alternative to steel tubing showcased in Booth #2141
Sernova Corp., a clinical-stage regenerative medicine company, is pleased to announce that it has completed a first closing of $2,333,500 of its non-brokered private placement, of which $64,000 was closed under the “Existing Shareholder Exemption.”
PRESS RELEASES